Application submitted for new drug approval

Comments

  • Texas_wedge
    Texas_wedge Member Posts: 2,798
    Tivozanib
    Yes - another weapon in the armoury and a promising one too. Not only does it address three different pathways but, if my memory serves me correctly, it has the added benefit of being less vulnerable to the problem of cross-resistance.
  • angec
    angec Member Posts: 924 Member

    Tivozanib
    Yes - another weapon in the armoury and a promising one too. Not only does it address three different pathways but, if my memory serves me correctly, it has the added benefit of being less vulnerable to the problem of cross-resistance.

    Info from Sloans on new drug!
    http://www.mskcc.org/blog/new-drug-shows-promise-patients-advanced-kidney